Advisory Services in Life Science Sector
Replicon Group's one special focus area is Life Science sector. In this sector we provide wide variety of business, financing and investment advisory services to clients ranging from public sector organizations to private companies and institutional investors.
Replicon possesses extensive domestic and international network in Life Science sector. Especially partnering to USA is facilitated by the fact that one of our partners is located in New York. Additionally Replicon's expert team consists of professionals from different fields of Life Science industries and research, e.g. Big Pharma experience, clinical trials, diagnostics and imaging, genetics, proteomics, biochemistry, and bioinformatics.
Project and Company Valuations and Technology Assessments in Life Sciences
See description on standard, state-of-art Valuation Services and our speciality service for e.g. drug development projects: Monte Carlo simulation.
MDF Portfolio Management Advisory for Institutional Investors
Replicon Medical Development Fund (earlier name Replicon Biotech Value or RBV) is formed from listed global drug development companies. Further information from following links:
See also: Company News (Jan 28 2003, Jan 29 2004, Jan 29 2005, Jan 30 2006, and Jan 29 2007), or contact Replicon. Replicon Asset Management is a registered trade mark of Replicon Oy/Ltd.
Business Development in Life Sciences
- Public Private Partnerships
- Strategy and Business Development Assistance
- International networking and Commercializations
- Market Intelligence
List of Replicon’s professionals and short biographies can be found in Professionals. See also chart on Replicon Life Science Expert Team.
Click here for references. See also chart related to long term business development of Replicon: Long Term Projects in Life Science sector.
|
